Arlene Sereno

652 total citations
10 papers, 393 citations indexed

About

Arlene Sereno is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Arlene Sereno has authored 10 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Arlene Sereno's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (5 papers) and CAR-T cell therapy research (3 papers). Arlene Sereno is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Glycosylation and Glycoproteins Research (5 papers) and CAR-T cell therapy research (3 papers). Arlene Sereno collaborates with scholars based in United States and Germany. Arlene Sereno's co-authors include Stephen J. Demarest, Flora Huang, Xiufeng Wu, Brian Kuhlman, Steven M. Lewis, Elaine M. Conner, Aaron K. Chamberlain, Stephanie M.E. Truhlar, Eric M. Smith and Christophe Hansen‐Estruch and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Nature Biotechnology.

In The Last Decade

Arlene Sereno

9 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arlene Sereno United States 8 282 273 116 103 30 10 393
Caroline Ekblad Sweden 12 329 1.2× 308 1.1× 178 1.5× 87 0.8× 32 1.1× 13 563
Yune Z. Kunes United States 5 353 1.3× 225 0.8× 124 1.1× 83 0.8× 26 0.9× 8 472
Alice Bakker United States 3 264 0.9× 167 0.6× 54 0.5× 61 0.6× 26 0.9× 8 349
Jochem Gokemeijer United States 9 275 1.0× 258 0.9× 138 1.2× 176 1.7× 20 0.7× 18 460
Anna Park United States 10 320 1.1× 392 1.4× 166 1.4× 101 1.0× 21 0.7× 17 514
Julie A. Lofgren United States 9 198 0.7× 142 0.5× 209 1.8× 58 0.6× 12 0.4× 10 361
John Haugner United States 7 239 0.8× 86 0.3× 190 1.6× 138 1.3× 13 0.4× 7 383
Vladimir Bobkov Netherlands 10 202 0.7× 158 0.6× 100 0.9× 96 0.9× 13 0.4× 15 337
Andreas Nechansky Austria 12 237 0.8× 201 0.7× 79 0.7× 205 2.0× 63 2.1× 23 446
Toshihide Nishibata Japan 6 362 1.3× 63 0.2× 161 1.4× 75 0.7× 14 0.5× 8 492

Countries citing papers authored by Arlene Sereno

Since Specialization
Citations

This map shows the geographic impact of Arlene Sereno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arlene Sereno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arlene Sereno more than expected).

Fields of papers citing papers by Arlene Sereno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arlene Sereno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arlene Sereno. The network helps show where Arlene Sereno may publish in the future.

Co-authorship network of co-authors of Arlene Sereno

This figure shows the co-authorship network connecting the top 25 collaborators of Arlene Sereno. A scholar is included among the top collaborators of Arlene Sereno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arlene Sereno. Arlene Sereno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Froning, Karen, Arlene Sereno, Flora Huang, & Stephen J. Demarest. (2022). Generalizable design parameters for soluble T cell receptor-based T cell engagers. Journal for ImmunoTherapy of Cancer. 10(3). e004281–e004281. 2 indexed citations
2.
Poussin, Mathilde, Arlene Sereno, Xiufeng Wu, et al.. (2021). Dichotomous impact of affinity on the function of T cell engaging bispecific antibodies. Journal for ImmunoTherapy of Cancer. 9(7). e002444–e002444. 21 indexed citations
3.
Froning, Karen, Jack B. Maguire, Arlene Sereno, et al.. (2020). Computational stabilization of T cell receptors allows pairing with antibodies to form bispecifics. Nature Communications. 11(1). 2330–2330. 22 indexed citations
4.
Lewis, Steven M., Cody Fine, Brian Kuhlman, et al.. (2020). Fab-based bispecific antibody formats with robust biophysical properties and biological activity. UNC Libraries.
5.
Wu, Xiufeng, Arlene Sereno, Flora Huang, et al.. (2015). Protein design of IgG/TCR chimeras for the co-expression of Fab-like moieties within bispecific antibodies. mAbs. 7(2). 364–376. 22 indexed citations
6.
Wu, Xiufeng, Arlene Sereno, Flora Huang, et al.. (2015). Fab-based bispecific antibody formats with robust biophysical properties and biological activity. mAbs. 7(3). 470–482. 52 indexed citations
7.
Lewis, Steven M., Xiufeng Wu, Anna Pustilnik, et al.. (2014). Generation of bispecific IgG antibodies by structure-based design of an orthogonal Fab interface. Nature Biotechnology. 32(2). 191–198. 196 indexed citations
8.
Dong, Jianying, Stephen J. Demarest, Arlene Sereno, et al.. (2010). Combination of Two Insulin-Like Growth Factor-I Receptor Inhibitory Antibodies Targeting Distinct Epitopes Leads to an Enhanced Antitumor Response. Molecular Cancer Therapeutics. 9(9). 2593–2604. 48 indexed citations
9.
Dong, Jianying, Antonio Boccia, Arlene Sereno, et al.. (2008). BIIB022, a human antibody targeting human insulin-like growth factor-1 receptor (IGF-1R), enhances the anti-tumor activities of Tarceva in non-small cell lung carcinoma (NSCLC) and Rapamycin in sarcoma cell lines. 68. 4002–4002. 7 indexed citations
10.
Zhu, Hengyi, K Ramnarayan, Jerry M. Anchin, et al.. (1995). Glu-96 of Basic Fibroblast Growth Factor Is Essential for High Affinity Receptor Binding. Journal of Biological Chemistry. 270(37). 21869–21874. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026